Quest Diagnostics, Inc. (DGX) Posts Mixed Q2 Results; Guides FY11 EPS In-Line
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $246.45 -0.4%
EPS Growth %: +10.0%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +10.0%
Financial Fact:
Income tax expense: -95M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 adjusted EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.92 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Children's Place (PLCE) Misses Q2 EPS by 20c
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
